BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
Publication
, Journal Article
Walter, EB; Talaat, KR; Gurtman, A
Published in: N Engl J Med
February 10, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
February 10, 2022
Volume
386
Issue
6
Start / End Page
606
Location
United States
Related Subject Headings
- Vaccination
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Child
- COVID-19 Vaccines
- COVID-19
- BNT162 Vaccine
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Walter, E. B., Talaat, K. R., & Gurtman, A. (2022). BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med, 386(6), 606. https://doi.org/10.1056/NEJMc2118775
Walter, Emmanuel B., Kawsar R. Talaat, and Alejandra Gurtman. “BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med 386, no. 6 (February 10, 2022): 606. https://doi.org/10.1056/NEJMc2118775.
Walter EB, Talaat KR, Gurtman A. BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med. 2022 Feb 10;386(6):606.
Walter, Emmanuel B., et al. “BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med, vol. 386, no. 6, Feb. 2022, p. 606. Pubmed, doi:10.1056/NEJMc2118775.
Walter EB, Talaat KR, Gurtman A. BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med. 2022 Feb 10;386(6):606.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
February 10, 2022
Volume
386
Issue
6
Start / End Page
606
Location
United States
Related Subject Headings
- Vaccination
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Child
- COVID-19 Vaccines
- COVID-19
- BNT162 Vaccine
- 42 Health sciences
- 32 Biomedical and clinical sciences